Abstract
Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.
Publication types
-
Case Reports
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Abdominal Neoplasms / diagnostic imaging
-
Abdominal Neoplasms / secondary*
-
Adenocarcinoma / diagnostic imaging
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / secondary*
-
Adult
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Camptothecin / administration & dosage
-
Colectomy
-
Colonic Neoplasms / drug therapy*
-
Fluorodeoxyglucose F18*
-
Fluorouracil / administration & dosage
-
Follow-Up Studies
-
Humans
-
Lymphatic Metastasis / diagnostic imaging*
-
Male
-
Radionuclide Imaging
-
Radiopharmaceuticals*
-
Remission Induction
-
Tomography, X-Ray Computed*
Substances
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents, Phytogenic
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18
-
Fluorouracil
-
Camptothecin